| |
| |
|
| Insider
Information: |
Posner Brian S |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
158,715 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,546,008 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
158,715 |
|
|
| Total
Value |
$14,546,008 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
1
|
|
Stock
price went up :
|
4
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
1.0
|
| Percentage
Gain/Loss : |
 41.0%
|
19.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
LMP Capital & Income Fund Inc |
SCD |
Officer of the Adviser |
2006-10-11 |
5,000 |
2006-10-11 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Director |
2021-07-01 |
8,175 |
2009-06-03 |
0 |
Premium* |
|
|
Arch Capital Group Ltd |
ACGL |
|
2024-05-09 |
125,540 |
2011-11-04 |
0 |
Premium* |
|
|
Bg Medicine, Inc. |
BGMD |
Director |
2012-11-19 |
20,000 |
2012-05-22 |
0 |
Premium* |
|
|
Bioverativ Inc. |
BIVV |
Director |
2018-03-08 |
0 |
2017-04-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2015-02-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
250 |
5,450 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2014-07-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
300 |
5,700 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2019-02-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
315 |
6,895 |
0 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2011-11-04 |
4 |
A |
$0.00 |
$0 |
D/D |
332 |
332 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2021-06-04 |
4 |
AS |
$274.17 |
$98,701 |
D/D |
(360) |
7,400 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2015-06-15 |
4 |
AS |
$386.64 |
$154,656 |
D/D |
(400) |
5,745 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2015-06-22 |
4 |
AS |
$415.00 |
$195,050 |
D/D |
(470) |
5,275 |
0 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2018-11-28 |
4 |
B |
$28.24 |
$14,119 |
D/D |
500 |
85,127 |
2.39 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2018-11-28 |
4 |
B |
$21.86 |
$10,932 |
D/D |
500 |
3,000 |
2.39 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2014-06-20 |
4 |
AS |
$315.00 |
$190,575 |
D/D |
(605) |
6,000 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
695 |
6,145 |
0 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2017-09-25 |
4 |
D |
$25.00 |
$17,375 |
D/D |
(695) |
2,146 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2014-06-13 |
4 |
AS |
$310.50 |
$217,350 |
D/D |
(700) |
6,605 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2021-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
775 |
8,175 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2014-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
870 |
7,305 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2018-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
880 |
7,210 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
890 |
7,885 |
0 |
- |
|
| BIVV |
Bioverativ Inc. |
Director |
• • – |
2017-08-09 |
4 |
B |
$59.19 |
$59,190 |
D/D |
1,000 |
6,693 |
2.81 |
- |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2020-05-06 |
4 |
B |
$23.72 |
$23,718 |
D/D |
1,000 |
92,685 |
2.39 |
% |
|
| ACGL |
Arch Capital Group Ltd |
Director |
– • – |
2020-05-13 |
4 |
B |
$22.16 |
$22,159 |
D/D |
1,000 |
103,801 |
2.39 |
% |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2017-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,055 |
7,414 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2019-12-02 |
4 |
AS |
$292.35 |
$308,429 |
D/D |
(1,055) |
6,995 |
0 |
- |
|
| BIVV |
Bioverativ Inc. |
Director |
• • – |
2017-04-17 |
4 |
A |
$56.83 |
$60,012 |
D/D |
1,056 |
3,693 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2016-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,060 |
6,335 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
• • – |
2017-06-09 |
4 |
AS |
$256.31 |
$277,840 |
D/D |
(1,084) |
6,330 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
